Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cells

Journal of Neuroscience Methods

Volumn 163, Issue 2, 2007, Pages 310-320

  Liu, Danni ^a   McIlvain, H Beal ^a   Fennell, Myles ^a   Dunlop, John ^a   Wood, Andrew ^a   Zaleska, Margaret M ^a   Graziani, Edmund I ^b   Pong, Kevin ^a  

^a PFIZER INC   (United States)

^b WYETH RESEARCH   (United States)

Author keywords

Amyotrophic lateral sclerosis; Immunophilin ligands; Neurite outgrowth; Neuronal survival; Neuroregeneration; Parkinson's disease; Spinal cord injury; Stroke

Indexed keywords

IMMUNOPHILIN;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NERVE CELL CULTURE; NERVE FIBER GROWTH; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; BIOLOGICAL ASSAY; CELL COUNT; CELL CULTURE TECHNIQUES; CELL ENLARGEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOPHILINS; IMMUNOSUPPRESSIVE AGENTS; LIGANDS; NEURITES; NEUROFILAMENT PROTEINS; OPTICS; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34249874875     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.03.018     Document Type: Article

References (70)

1. Abraham R.T., and Wiederrecht G.J. Immunopharmacology of rapamycin. Annu Rev Immunol 14 (1996) 483-510
2. Alessandri B., Rice A.C., Levasseur J., DeFord M., Hamm R.J., and Bullock M.R. Cyclosporin A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats. J Neurotrauma 19 7 (2002) 829-841
3. Armistead DM. Novel immunosuppressive compounds. WO9219593, 1992.
4. Avramut M., Zeevi A., and Achim C.L. The immunosuppressant drug FK506 is a potent agent for human fetal neurons. Brain Res Dev Brain Res 132 2 (2001) 151-157
5. Bavetta S., Hamlyn P.J., Burnstock G., Lieberman A.R., and Anderson P.N. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp Neurol 158 2 (1999) 382-393
6. Birge R.B., Wadsworth S., Akakura R., Abeysinghe H., Kanojia R., MacIelag M., et al. A role for schwann cells in the neuroregenerative effects of a non-immunosuppressive FK506 derivative, JNJ460. Neuroscience 124 2 (2004) 351-366
7. Chen Q.S., Wei W.Z., Shimahara T., and Xie C.W. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem 77 3 (2002) 354-371
8. Choo Y.S., Johnson G.V., MacDonald M., Detloff P.J., and Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13 14 (2004) 1407-1420
9. Costantini L.C., and Isacson O. Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture. Exp Neurol 164 1 (2000) 60-70
10. Costantini L.C., Cole D., Chaturvedi P., and Isacson O. Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease. Eur J Neurosci 13 6 (2001) 1085-1092
11. Dawson T.M., Steiner J.P., Lyons W.E., Fotuhi M., Blue M., and Snyder S.H. The immunophilins, FK506 binding protein and cyclophilin are discretely localized in the brain: relationship to calcineurin. Neuroscience 62 2 (1994) 569-580
12. Diaz-Ruiz A., Rios C., Duarte I., Correa D., Guizar-Sahagun G., Grijalva I., et al. Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats. Neurosci Lett 266 1 (1999) 61-64
13. Dubowchik G.M., Vrudhula V.M., Dasgupta B., Ditta J., Chen T., Sheriff S., et al. 2-Aryl-2,2-difluoroacetamide FKBP12 ligands: synthesis and X-ray structural studies. Org Lett 3 25 (2001) 3987-3990
14. Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T., and Schmid F.X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337 6206 (1989) 476-478
15. Francel P.C., Harris K., Smith M., Fishman M.C., Dawson G., and Miller R.J. Neurochemical characteristics of a novel dorsal root ganglion × neuroblastoma hybrid cell line, F-11. J Neurochem 48 5 (1987) 1624-1631
16. Gold B.G., Voda J., Yu X., McKeon G., and Bourdette D.N. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis. J Neurosci Res 77 3 (2004) 367-377
17. Griffith J.P., Kim J.L., Kim E.E., Sintchak M.D., Thomson J.A., Fitzgibbon M.J., et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 82 3 (1995) 507-522
18. Guo X., Dawson V.L., and Dawson T.M. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur J Neurosci 13 9 (2001) 1683-1693
19. Hamilton GS, Steiner SP, Small molecule inhibitors of rotamase enzyme activity. WO9640633, 1996.
20. Harding M.W., Galat A., Uehling D.E., and Schreiber S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341 6244 (1989) 758-760
21. Julien J.P., and Mushynski W.E. Neurofilaments in health and disease. Nucl Acid Res Mol Biol 61 (1998) 1-20
22. Kano Y., Nohno T., Hasegawa T., Takahashi R., Hiragami F., Kawamura K., et al. Immunosuppressnat FK506 induces neurite outgrowth in PC12 mutant cells with impaired NGF-promoted neuritgenesis via a novel MAP kinase signaling pathway. Neurochem Res 27 12 (2002) 1655-1661
23. Keep M., Elmer E., Fong K.S., and Csiszar K. Intrathecal cyclosporin prolongs survival of late-stage ALS mice. Brain Res 894 2 (2001) 327-331
24. Kitamura Y., Itano Y., Kubo T., and Nomura Y. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. J Neuroimmunol 50 2 (1994) 221-224
25. Klettner A., Baumgrass R., Zhang Y., Fischer G., Burger E., Herdegen T., et al. the neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin. Brain Res Mol Brain Res 97 1 (2001) 21-31
26. Kupina N.C., Detloff M.R., Dutta S., and Hall E.D. Neuroimmunophilin ligand V-10,367 is neuroprotective after 24-h delayed administration in a mouse model of diffuse traumatic brain injury. J Cereb Blood Flow Metab 22 10 (2002) 1212-1221
27. Lee M.K., and Cleveland D.W. Neuronal intermediate filaments. Annu Rev Neurosci 19 (1996) 187-217
28. Lench N.J., Macadam R., and Markham A.F. The human gene encoding FKBP-rapamycin associated protein (FRAP) maps to chromosomal band 1p36.2. Hum Genet 99 4 (1997) 547-549
29. Liu D., Popiolek M., Wood A., Zaleska M.M., Graziani E.I., and Pong K. Neurotrophic activity of Immunophilin ligands in cultured neurons: quantitative analysis by a neurofilament ELISA. Soc Neurosci Abstr 35 (2004) 104.2
30. Lyons W.E., George E.B., Dawson T.M., Steiner J.P., and Snyder S.H. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci USA 91 8 (1994) 3193-3195
31. Lyons W.E., Steiner J.P., Snyder S.H., and Dawson T.M. Neuronal regeneration enhances the expression of the immunophilin FKBP-12. J Neurosci 15 4 (1995) 2985-2994
32. McIlvain H.B., Baudy A., Sullivan K., Liu D., Pong K., Fennell M., et al. Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F-11 cell line through a PKA-dependent pathway. Brain Res 1077 1 (2006) 16-23
33. Nixon R.A., and Shea T.B. Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motil Cytoskel 22 (1992) 81-91
34. Nixon R.A. Dynamic behavior and organization of cytockeletal proteins in neurons: reconciling old and new findings. Bioessays 98 (1998) 229-238
35. Ohuchi T., Maruoka S., Sakudo A., and Arai T. Assay-based quantitative analysis of PC12 cell differentiation. J Neurosci Meth 118 (2002) 1-8
36. Okonkwo D.O., Buki A., Siman R., and Povlishock J.T. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 10 2 (1999) 353-358
37. Parker E.M., Monopoli A., Ongini E., Lozza G., and Babij C.M. Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression. Neuropharmacology 39 10 (2000) 1913-1919
38. Pong K., Doctrow S.R., Huffman K., Adinolfi C.A., and Baudry M. Attenuation of staurosporine-induced apoptosis, oxidative stress, and mitochondrial dysfunction by synthetic superoxide dismutase and catalase mimetics, in cultured cortical neurons. Exp Neurol 171 (2001) 84-97
39. Pong K., and Zaleska M.M. Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases. Curr Drug Targets-CNS Neurol Dis 2 (2003) 349-356
40. Price R.D., Yamaji T., Yamamoto H., Higashi Y., Hanaoka K., Yamazaki S., et al. FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action. Eur J Pharmacol 509 1 (2005) 11-19
41. Ravikumar B., Duden R., and Rubinsztein D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11 9 (2002) 1107-1117
42. Ravikumar B., Stewart A., Kita H., Kato K., Duden R., and Rubinsztein D.C. Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. Hum Mol Genet 12 9 (2003) 985-994
43. Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36 6 (2004) 585-595
44. Rosenstiel P., Schramm P., Isenmann S., Brecht S., Eickmeier C., Burger E., et al. Differential effects of immunophilin-ligands (FK506 and V-10,367) on survival and regeneration of rat retinal ganglion cells in vitro and after optic nerve crush in vivo. J Neurotrauma 20 3 (2003) 297-307
45. Ross D.T., Guo H., Howorth P., Chen Y., Hamilton G.S., and Steiner J.P. The small molecule FKBP ligand GPI-1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats. Neurosci Lett 297 2 (2001) 113-116
46. Sabatini D.M., Erdjument-Bromage H., Lui M., Tempst P., and Snyder S.H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78 1 (1994) 35-43
47. Sauer H., Francis J.M., Jiang H., Hamilton G.S., and Steiner J.P. Systemic treatment with GPI-1046 improves spatial memory and reverses cholinergic neuron atrophy in the media septal nucleus of aged mice. Brain Res 842 1 (1999) 109-118
48. Schreyer D.J., Andersen P.L., Williams K., Kosatka I., and Truong T.N. Quantitative analysis of GAP-43 expression by neurons in microcultures using cell-ELISA. J Neurosci Meth 72 (1997) 137-145
49. Sehgal S.N., Baker H., and Vezina C. Rapamycin (AY-22989), a new antifungal antibiotic. II. Fermentation, isolation, and characterization. J Antibiot 28 10 (1975) 727-732
50. Sharkey J., and Butcher S.P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia. Nature 371 6495 (1994) 336-339
51. Sharkey J., Crawford J.H., Butcher S.P., and Marston H.M. Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. Stroke 27 12 (1996) 2282-2286
52. Siekierka J.J., Hung S.H., Poe M., Lin C.S., and Sigal N.H. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341 6244 (1989) 755-757
53. Simpson P.B., Bacha J.I., Palfreyman E.L., Woollacott A.J., McKernan R.M., and Kerby J. Retinoic acid evoked-differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis. Anal Biochem 298 2 (2001) 163-169
54. Singleton R.H., Stone J.R., Okonkwo D.O., Pellicane A.J., and Powlishock J.T. The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. J Neurotrauma 18 6 (2001) 607-614
55. Skotnicki JS, Leone CL, Schiehser GA. Rapamycin hydroxyesters. US5362718, 1994.
56. Small S.L., Fukui M.B., Bramblett G.T., and Eidelman B.H. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol 40 4 (1996) 575-580
57. Steiner J.P., Connolly M.A., Valentine H.L., Hamilton G.S., Dawson T.M., Hester L., et al. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin, and cyclosporin A. Nat Med 3 4 (1997) 421-428
58. Steiner J.P., Hamilton G.S., Ross D.T., Valentine H.L., Guo H., Connolly M.A., et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci USA 94 5 (1997) 2019-2024
59. Stover J.R., Schoning B., Sakowitz O.W., Woiciechowsky C., and Unterberg A.W. Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis factor-alpha following controlled cortical impact injury in rats. J Neurosurg 94 5 (2001) 782-787
60. Sullivan P.G., Thompson M.B., and Scheff S.W. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 160 1 (1999) 226-234
61. Summers M.Y., Leighton M., Liu D., Pong K., and Graziani E.I. 3-Normeridamycin: a potent non-immunosuppressive immunophilin ligand is neuroprotective in dopaminergic neurons. J Antibiot 59 3 (2006) 184-189
62. Takahashi N., Hayano T., and Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporine A-binding protein cyclophilin. Nature 337 6206 (1989) 473-475
63. Tang S.J., Reis G., Kang H., Gingras A.C., Sonenberg N., and Schuman E.M. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci USA 99 1 (2002) 467-472
64. Terashima A., Taniguchi T., Nakai M., Yasuda M., Kawamata T., and Tanaka C. Rapamycin and FK506 induce long-term potentiation by pairing stimulation via intracellular Ca(2+) signaling mechanism in rat hippocampal CA1 neurons. Neuropharmacology 39 10 (2000) 1920-1928
65. Wang M.S., and Gold B.G. FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft. J Spinal Cord Med 22 4 (1999) 287-296
66. Wood A., Liu D., Mark R., Campos S., McIlvain H.B., Fennell M., et al. Stimulation of neurite outgrowth by immunophilin ligands: quantitative analysis by cellomics arrayscan. Soc Neurosci Abstr (2004) 104.3
67. Yabe T., Samuels I., and Schwartz J.P. Bone morphogenetic proteins BMP-6 and BMP-7 have differential effects on survival and neurite outgrowth of cerebellar granule cell neurons. J Neurosci Res 68 (2002) 161-168
68. Young L., Bilsland J., and Harper S. A rapid method for determination of cell survival in primary neuronal DRG cultures. J Neurosci Meth 93 (1999) 81-89
69. Yu K., Toral-Barza L., Discafani C., Zhang W.G., Skotnicki J., Frost P., et al. MTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer 8 3 (2001) 249-258
70. Zhang C., Steiner J.P., Hamilton G.S., Hicks T.P., and Poulter M.O. Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment. J Neurosci 21 15 (2001) 1-6